vacuolartyp
hatpas
vatpas
major
proton
pump
respons
acidif
intracellular
compart
eukaryot
cell
enzym
consist
two
multisubunit
complex
solubl
subcomplex
catalyz
atp
hydrolysi
transmembran
vo
subcomplex
requir
proton
transport
across
membran
cell
type
vatpas
express
endomembran
system
regul
maintain
acid
ph
intracellular
compart
lysosom
endosom
golgi
apparatu
secretori
granul
coat
vesicl
function
vatpas
essenti
cellular
process
vesicular
traffick
receptormedi
endocytosi
protein
degrad
process
special
cell
type
includ
osteoclast
renal
epitheli
cell
vatpas
also
express
plasma
membran
pump
proton
extracellular
space
cancer
cell
vatpas
express
plasma
membran
order
elimin
toxic
cytosol
h
importantli
vatpas
contribut
acid
tumor
microenviron
lead
activ
proteas
thu
facilit
tumor
cell
migrat
invas
angiogenesi
sinc
inhibit
vatpas
shown
reduc
invas
cancer
cell
metastasi
format
enzym
emerg
promis
drug
target
recent
year
archazolid
b
highli
potent
specif
inhibitor
vatpas
first
isol
myxobacterium
archangium
gephyra
compound
inhibit
vatpas
low
nanomolar
concentr
bind
subunit
c
vo
complex
biolog
activ
compar
vatpas
inhibitor
bafilomycin
concanamycin
archazolid
natur
compound
high
interest
use
tool
studi
consequ
vatpas
inhibit
lead
drug
develop
archazolid
either
produc
ferment
total
synthesi
field
cancer
research
sever
studi
report
interest
pharmacolog
effect
archazolid
reduc
migrat
differ
invas
tumor
cell
vitro
cancer
cell
metastasi
vivo
breast
tumor
mous
model
furthermor
archazolid
activ
pathway
cellular
stress
respons
apoptosi
highli
invas
tumor
cell
classic
activ
macrophag
archazolid
select
induc
gener
tumor
necrosi
factor
may
indirectli
promot
tumor
suppress
role
vatpas
endotheli
cell
rare
investig
endothelium
play
crucial
role
pathogenesi
progress
cancer
metastat
cascad
includ
local
angiogenesi
site
primari
tumor
adhes
tumor
cell
site
metastasi
angiogenesi
develop
new
blood
vessel
exist
one
depend
prolifer
migrat
differenti
endotheli
cell
process
ensur
nutrient
suppli
tumor
growth
circul
cancer
cell
adher
endothelium
distant
site
adhes
interact
mediat
receptor
correspond
ligand
express
tumor
endotheli
cell
vatpas
report
regul
intracellular
ph
cell
migrat
microvascular
endotheli
cell
recent
studi
show
inhibit
vatpas
concanamycin
prevent
prolifer
reduc
migrat
impair
angiogenesisrel
signal
endotheli
cell
far
investig
role
endotheli
vatpas
process
tumor
cell
adhes
onto
endothelium
thu
interest
consequ
inhibit
endotheli
vatpas
archazolid
interact
endotheli
cancer
cell
variou
cell
adhes
molecul
endothelium
intercellular
adhes
molecul
vascular
cell
adhes
protein
eselectin
ncadherin
well
integrin
express
cancer
cell
report
mediat
cell
adhes
cancer
cell
onto
endotheli
cell
accordingli
focus
cell
adhes
molecul
integrin
first
time
studi
reveal
link
function
vatpas
adhes
transmigr
properti
endotheli
cell
archazolid
hereinaft
refer
archazolid
kindli
provid
prof
dr
rolf
saarland
univers
prof
dr
dirk
mench
univers
bonn
compound
dissolv
dimethylsulfoxid
dmso
stock
mm
archazolid
store
work
stock
store
treatment
cell
archazolid
dilut
cultur
medium
maxim
concentr
dmso
collagen
g
fetal
calf
serum
fc
purchas
biochrom
berlin
germani
recombin
tumor
necrosi
factor
peprotech
hamburg
germani
bovin
serum
albumin
bsa
carl
roth
karlsruh
germani
celltrack
green
cmfda
dye
thermo
fisher
scientif
schwert
germani
human
plasma
fibronectin
merck
darmstadt
germani
biolamina
sundbyberg
sweden
human
umbil
vein
endotheli
cell
huvec
obtain
pelobiotech
planeggmartinsri
germani
immort
human
microvascular
endotheli
cell
provid
center
diseas
control
prevent
lot
cdc
atlanta
ga
usa
type
endotheli
cell
cultiv
collagen
gcoat
phosphatebuff
salin
pb
flask
seed
collagen
gcoat
cell
cultur
dish
plate
use
endotheli
cell
growth
medium
easi
ecgm
pelobiotech
supplement
fc
uml
penicillin
streptomycin
panbiotech
aidenbach
germani
amphotericin
b
panbiotech
mixtur
supplement
provid
pelobiotech
human
breast
cancer
cell
line
prostat
cancer
cell
line
obtain
leibniz
institut
dsmzgerman
collect
microorgan
cell
cultur
braunschweig
germani
cell
type
cultiv
dulbecco
modifi
eagl
medium
dmem
contain
gl
glucos
panbiotech
supplement
fc
uml
penicillin
streptomycin
cell
type
cultiv
celltiterblu
cell
viabil
assay
promega
mannheim
germani
perform
accord
manufactur
protocol
determin
cell
viabil
cell
treatment
archazolid
assay
base
abil
metabol
activ
cell
reduc
resazurin
result
fluoresc
resorufin
celltiterblu
reagent
ad
cell
h
endpoint
treatment
fluoresc
measur
infinit
pro
micropl
reader
tecan
switzerland
nm
excit
nm
emiss
cytotox
nonradioact
cytotox
assay
promega
perform
accord
manufactur
instruct
determin
lactat
dehydrogenas
ldh
releas
treatment
archazolid
lysi
buffer
ad
untreat
cell
min
end
treatment
induc
releas
enzym
ldh
cytosol
enzym
releas
leaki
cell
releas
ldh
catalyz
enzymat
convers
lactat
pyruv
provid
nadh
convers
iodonitrotetrazolium
violet
red
formazan
product
presenc
diaphoras
absorb
measur
varioskan
flash
micropl
reader
thermo
fisher
scientif
nm
lysotrack
red
life
technolog
thermo
fisher
scientif
dye
measur
ph
valu
viabl
cell
huvec
cultur
confluenc
collagen
gcoat
ibidi
martinsri
germani
treat
archazolid
h
hoechst
sigmaaldrich
munich
germani
use
visual
nuclei
nm
lysotrack
red
use
visual
acid
compart
correspond
lysosom
dye
incub
min
acquisit
singl
imag
leica
b
fluoresc
microscop
leica
microsystem
wetzlar
germani
huvec
seed
collagen
gcoat
plate
grown
confluenc
two
day
treatment
cell
incub
indic
concentr
archazolid
h
untreat
cell
label
celltrack
green
cmfda
dye
serumfre
dmem
min
cell
per
well
ad
huvec
allow
adher
variou
time
point
nonadher
tumor
cell
wash
three
time
pb
contain
tumor
cell
adhes
determin
fluoresc
measur
infinit
pro
micropl
reader
tecan
nm
excit
nm
emiss
block
integrin
subunit
cell
celltrack
greenlabel
cell
incub
antiintegrin
antibodi
abcam
cambridg
unit
kingdom
concentr
antibodi
per
one
million
cell
ml
dmem
ad
archazolidtr
huvec
cell
wash
dmem
block
integrin
subunit
huvec
cell
incub
antiintegrin
antibodi
ecgm
huvec
wash
ecgm
untreat
cell
ad
huvec
adhes
cell
onto
extracellular
matrix
ecm
compon
plate
coat
collagen
g
pb
human
plasma
fibronectin
pb
dulbecco
pb
dpb
contain
overnight
adhes
cell
onto
three
promin
ecm
compon
carri
describ
min
adhes
huvec
grown
porou
filter
membran
transwel
insert
polycarbon
membran
pore
corn
new
york
usa
h
treat
indic
untreat
cell
label
celltrack
green
cmfda
dye
describ
section
cell
adhes
assay
resuspend
medium
panbiotech
contain
bsa
huvec
wash
twice
medium
contain
bsa
cell
allow
transmigr
endotheli
monolay
h
medium
contain
bsa
use
neg
control
medium
contain
fc
use
chemoattract
transmigr
lower
compart
nonmigr
cell
remain
upper
compart
care
remov
use
cotton
swab
transmigr
cell
lyse
radioimmunoprecipit
assay
ripa
buffer
transmigr
quantifi
measur
fluoresc
signal
nm
excit
nm
emiss
huvec
grown
confluenc
plate
treat
archazolid
h
cell
induc
upregul
gene
express
cell
adhes
molecul
rna
isol
use
rneasi
mini
kit
qiagen
hilden
germani
accord
manufactur
protocol
oncolumn
dnase
digest
perform
remov
genom
dna
rna
transcrib
cdna
superscript
ii
life
technolog
thermo
fisher
scientif
qpcr
experi
perform
use
steponeplu
system
appli
biosystem
thermo
fisher
scientif
data
analyz
stepon
steponeplu
softwar
power
sybr
green
pcr
master
mix
life
technolog
compar
ct
quantit
method
use
follow
primer
use
qpcr
experi
forward
ctg
ctc
ggg
gct
ctg
revers
aac
aac
ttg
ggc
tgg
tca
forward
cca
cag
taa
ggc
agg
ctg
revers
gct
gga
aca
ggt
cat
ggt
eselectin
forward
aga
tga
gga
ctg
cgt
gga
revers
gtg
gcc
act
gca
gga
tgt
ncadherin
forward
cag
gaa
aag
tgg
caa
gtg
revers
agg
aaa
agg
tcc
cct
gga
gapdh
forward
cca
cat
cgc
tca
gac
acc
revers
tga
agg
ggt
cat
tga
tgg
threshold
cycl
target
gene
normal
threshold
cycl
gapdh
gene
huvec
grown
confluenc
plate
treat
archazolid
h
cell
treat
h
induc
express
cell
adhes
molecul
subsequ
cell
detach
hyclon
hyqtas
ge
healthcar
freiburg
germani
case
detach
cell
fix
formaldehyd
polysci
hirschberg
der
germani
pb
min
wash
pb
incub
fluorescein
isothiocyan
fitc
label
antihuman
mous
antibodi
biozol
ech
germani
room
temperatur
min
protein
cell
fix
wash
pb
incub
antibodi
phycoerythrin
pe
label
antihuman
mous
pelabel
antihuman
mous
eselectin
pelabel
antihuman
mous
ncadherin
becton
dickinson
ice
min
antibodi
dilut
pb
contain
bsa
surfac
express
cell
adhes
molecul
measur
flow
cytometri
facsvers
becton
dickinson
heidelberg
germani
stain
surfac
collagen
huvec
cell
incub
antihuman
collagen
antibodi
rabbit
abcam
ice
min
stain
procedur
perform
ice
ensur
surfac
protein
antibodi
endocytos
cell
wash
pb
contain
fix
rotihistofix
carl
roth
alexa
fluor
antirabbit
antibodi
goat
life
technolog
use
secondari
antibodi
hoechst
sigmaaldrich
use
visual
nuclei
confluent
huvec
plate
treat
indic
cell
wash
icecold
pb
lyse
ripa
buffer
supplement
proteas
inhibitor
complet
mini
edtafre
roch
mannheim
germani
sodium
orthovanad
sodium
fluorid
phenylmethylsulphonyl
fluorid
sodium
pyrophosph
protein
determin
perform
use
pierc
bca
protein
assay
kit
thermo
fisher
scientif
equal
amount
protein
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
biorad
laboratori
munich
germani
separ
protein
transfer
onto
polyvinyliden
difluorid
membran
tank
blot
biorad
laboratori
immunodetect
membran
block
boltinggrad
milk
powder
carl
roth
tb
contain
tween
sigmaaldrich
follow
antibodi
use
mous
antihuman
cathepsin
b
antibodi
merck
mous
antibodi
sigmaaldrich
antimous
igg
hors
radish
peroxidas
hrp
link
antibodi
cell
signal
frankfurt
germani
imagej
version
use
densitometr
analysi
cathepsin
b
activ
assay
perform
describ
public
kubisch
et
al
confluent
huvec
seed
plate
treat
indic
cell
wash
pb
lyse
nondenatur
mper
mammalian
protein
extract
reagent
thermo
fisher
scientif
supplement
proteas
inhibitor
complet
mini
edtafre
roch
sodium
orthovanad
sodium
fluorid
phenylmethylsulphonyl
fluorid
fluorogen
cathepsin
b
substrat
hydrochlorid
sigmaaldrich
ad
cell
lysat
dilut
assay
buffer
supplement
mm
lcystein
sigmaaldrich
incub
min
fluoresc
measur
nm
excit
nm
emiss
micropl
reader
varioskan
flash
thermo
fisher
scientif
intens
fluoresc
signal
correspond
cathepsin
b
enzym
activ
background
subtract
cathepsin
b
inhibitor
enzo
life
scienc
germani
ad
addit
reaction
huvec
nucleofector
kit
lonza
cologn
germani
use
transfect
huvec
transfect
perform
accord
manufactur
protocol
use
plasmid
dna
cell
nucleofector
devic
lonza
h
transfect
cell
treat
experi
addgen
plasmid
hcathepsin
b
kindli
provid
hyeryun
choe
hcathepsin
b
digest
pmei
xbai
linear
dna
fragment
correspond
human
ctsb
gene
relig
gener
empti
delta
mc
plasmid
use
control
transfect
origin
backbon
hcathepsin
b
thermo
fisher
scientif
control
vector
delta
mc
use
transfect
clone
basi
hcathepsin
b
therefor
lack
almost
whole
part
multipl
clone
site
statist
analys
perform
use
graphpad
prism
san
diego
usa
oneway
anova
follow
tukey
posthoc
test
unpair
ttest
use
evalu
minimum
three
independ
experi
number
independ
perform
experi
n
state
correspond
figur
legend
p
consid
statist
signific
data
express
mean
standard
error
mean
sem
sinc
vatpas
inhibitor
archazolid
never
use
studi
endotheli
cell
first
perform
cytotox
assay
treat
confluent
huvec
nm
archazolid
h
observ
treatment
neither
influenc
metabol
activ
releas
ldh
h
fig
left
panel
metabol
activ
releas
ldh
slightli
affect
highest
concentr
archazolid
h
fig
right
panel
consequ
follow
experi
carri
h
less
archazolid
treatment
order
exclud
cytotox
effect
archazolid
within
experiment
set
microscop
analysi
reveal
also
integr
endotheli
monolay
affect
archazolid
cell
show
slightli
differ
morpholog
fig
archazolidtr
cell
swollen
compar
control
cell
unexpect
vacuol
endoplasm
reticulum
er
describ
cell
type
typic
vatpas
inhibitor
effect
obviou
subconflu
confluent
cell
fig
inhibit
vatpas
prevent
acidif
lysosom
use
cellperm
dye
lysotrack
red
possibl
label
acid
lysosom
live
cell
thu
dye
serv
indic
vatpas
inhibit
proof
archazolid
also
function
activ
vatpas
inhibitor
huvec
cell
treat
nm
archazolid
incub
lysotrack
red
hoechst
shown
fig
red
vesicular
stain
correspond
acidifi
lysosom
control
cell
disappear
complet
treatment
archazolid
summari
archazolid
treatment
h
cytotox
quiescent
huvec
inhibit
function
vatpas
analyz
adhes
cell
onto
huvec
confluent
huvec
treat
nm
archazolid
h
untreat
cell
label
celltrack
green
cmfda
dye
interestingli
vatpas
inhibit
strongli
increas
attach
metastat
breast
carcinoma
cell
line
onto
huvec
min
adhes
fig
also
investig
influenc
archazolid
transendotheli
migrat
cell
huvec
seed
boyden
chamber
treat
nm
archazolid
h
celltrack
greenlabel
cell
treat
archazolid
allow
transmigr
endotheli
monolay
h
shown
fig
archazolid
significantli
decreas
transendotheli
migrat
cell
influenc
archazolid
tumor
cell
adhes
studi
huvec
repres
macrovascular
endotheli
cell
also
microvascular
cell
moreov
besid
breast
cancer
cell
line
also
prostat
cancer
cell
use
second
metastat
cancer
cell
line
archazolid
treatment
endotheli
cell
increas
attach
cell
onto
monolay
min
adhes
fig
increas
attach
cell
onto
huvec
monolay
min
adhes
fig
note
adhes
nonmetastat
jurkat
cell
acut
cell
leukemia
cell
line
remain
unaffect
treatment
huvec
archazolid
fig
taken
togeth
archazolid
treatment
augment
adhes
properti
micro
macrovascular
endotheli
cell
metastat
tumor
cell
nonmetastat
one
note
cancer
cell
adhes
onto
archazolidactiv
endotheli
cell
increas
time
adhes
adhes
tumor
cell
onto
endothelium
principl
similar
leukocyt
slightli
differ
molecul
mediat
adhes
process
ligand
endotheli
cell
adhes
molecul
eselectin
ncadherin
found
express
tumor
cell
mediat
tumorendotheli
cell
interact
inhibit
vatpas
might
affect
express
endotheli
cell
adhes
molecul
mrna
protein
level
determin
mrna
express
eselectin
ncadherin
huvec
treat
archazolid
h
known
upregul
express
eselectin
thu
serv
posit
control
quantit
realtim
pcr
show
vatpas
inhibit
huvec
alter
mrna
level
eselectin
ncadherin
fig
protein
express
adhes
molecul
surfac
endotheli
cell
analyz
flow
cytometri
archazolid
nm
h
affect
cell
surfac
express
eselectin
ncadherin
fig
besid
eselectin
ncadherin
also
integrin
abl
mediat
process
cell
adhes
sinc
none
cell
adhes
molecul
express
huvec
regul
upon
archazolid
treatment
consid
integrin
potenti
interact
partner
within
protein
famili
report
mediat
tumor
cell
adhes
onto
quiescent
endotheli
cell
order
elucid
role
archazolidinduc
tumor
cell
adhes
integrin
block
either
cell
cell
huvec
note
experi
throughout
studi
endotheli
cell
treat
archazolid
block
cell
archazolidinduc
tumor
cell
adhes
reduc
almost
control
level
fig
left
panel
wherea
block
huvec
signific
effect
increas
tumor
cell
adhes
vatpas
inhibit
fig
right
panel
depend
subunit
varieti
ligand
includ
extracellular
matrix
ecm
compon
collagen
fibronectin
laminin
therefor
hypothes
archazolid
treatment
endotheli
cell
might
lead
upregul
compon
cell
allow
adher
onto
plastic
coat
ecm
compon
cell
adhes
assay
reveal
well
cell
favor
interact
ecm
compon
collagen
adhes
onto
collagen
much
higher
onto
uncoat
plastic
control
fig
cell
also
adher
fibronectinco
plastic
much
lesser
extent
compar
collagen
coat
therefor
focus
interact
two
tumor
cell
line
collagen
block
integrin
subunit
cell
clearli
abolish
interact
collagen
fig
indic
attach
tumor
cell
collagen
mediat
sinc
collagen
major
ecm
compon
cell
interact
next
step
prove
whether
vatpas
inhibit
influenc
amount
collagen
express
huvec
extracellular
matrix
detect
collagen
endotheli
surfac
archazolidtr
huvec
label
antibodi
collagen
type
iiv
ice
prevent
endocytosi
ensur
antibodi
bind
intracellular
collagen
interestingli
archazolid
increas
amount
surfac
collagen
huvec
fig
control
stain
perform
use
antibodi
cytosol
subunit
transcript
factor
nuclear
factor
show
intracellular
protein
detect
stain
method
fig
report
vatpas
inhibit
archazolid
impair
activ
cathepsin
b
lysosom
enzym
degrad
extracellular
matrix
compon
includ
collagen
collagen
degrad
cathepsin
b
activ
cathepsin
b
depend
vatpas
activ
suggest
accumul
collagen
surfac
endotheli
cell
might
consequ
impair
function
cathepsin
b
therefor
enzym
activ
assay
base
proteolysi
fluorogen
cathepsin
b
substrat
perform
archazolidtr
huvec
activ
cathepsin
b
strongli
decreas
approxim
compar
control
cell
archazolid
concentr
nm
fig
line
result
western
blot
analysi
show
archazolid
nm
reduc
protein
express
matur
activ
form
cathepsin
b
less
control
huvec
fig
proof
whether
archazolidinduc
tumor
cell
adhes
consequ
decreas
amount
cathepsin
b
huvec
transfect
plasmid
code
human
cathepsin
b
empti
vector
control
h
transfect
cell
treat
nm
archazolid
level
cathepsin
b
transfect
treatment
assess
western
blot
analysi
fig
overexpress
cathepsin
b
strongli
diminish
basal
archazolidinduc
adhes
cell
fig
target
proton
pump
vatpas
cancer
therapi
gain
great
interest
sinc
inhibit
report
reduc
invas
cancer
cell
importantli
also
metastasi
thu
intens
research
relat
vatpas
done
cancer
cell
wherea
studi
investig
vatpas
endotheli
cell
indic
role
migrat
prolifer
possibl
angiogenesi
present
studi
use
myxobacteri
natur
product
archazolid
investig
consequ
vatpas
inhibit
endothelium
tumorendotheli
cell
interact
first
time
abl
show
link
vatpas
adhes
transmigr
properti
endothelium
inhibit
vatpas
endotheli
cell
archazolid
significantli
increas
adhes
metastat
cancer
cell
decreas
transendotheli
migrat
cancer
cell
attribut
augment
collagen
level
surfac
archazolidtr
endotheli
cell
note
adhes
nonmetastat
jurkat
cell
line
onto
archazolidtr
endotheli
cell
remain
unaffect
archazolidinduc
adhes
tumor
cell
independ
endotheli
cell
adhes
molecul
eselectin
ncadherin
express
regul
compound
howev
found
archazolidinduc
tumor
cell
adhes
mediat
express
breast
cancer
prostat
cancer
cell
block
integrin
subunit
tumor
cell
revers
proadhes
effect
archazolid
adhes
experi
plastic
coat
extracellular
matrix
compon
could
show
cell
clearli
favor
interact
collagen
wherea
adhes
nonmetastat
jurkat
cell
larg
independ
extracellular
matrix
protein
fig
differ
adhes
properti
metastat
cancer
cell
jurkat
cell
might
result
distinct
integrin
express
pattern
cell
line
cell
express
repres
collagen
receptor
jurkat
cell
express
lack
receptor
fibronectin
shown
jurkat
cell
interact
human
endotheli
cell
express
cytokin
treatment
cell
transfect
result
line
previou
studi
show
express
cell
abl
rapidli
attach
collagen
cortic
bone
matrix
contrast
jurkat
cell
abl
adher
might
preferenti
interact
cell
adhes
molecul
rather
ecm
protein
addit
act
laminin
receptor
least
recogn
fibronectin
though
express
receptor
fibronectin
laminin
cell
adher
fibronectin
much
lesser
extent
adher
laminin
probabl
due
lower
affin
extracellular
matrix
compon
importantli
vatpas
inhibit
archazolid
increas
surfac
level
extracellular
matrix
compon
collagen
might
explain
increas
cell
onto
archazolidtr
huvec
independ
endotheli
cell
adhes
molecul
perform
live
cell
proteolysi
assay
cavallomedv
et
al
demonstr
ecm
degrad
particular
gelatin
collagen
iv
associ
activ
cathepsin
b
caveola
endotheli
cell
tube
format
addit
recent
studi
report
vatpas
inhibit
impair
activ
cathepsin
b
cancer
cell
therefor
suggest
accumul
collagen
endotheli
surfac
might
consequ
impair
cathepsin
b
activ
express
endotheli
cell
fact
confirm
impair
cathepsin
b
activ
archazolid
express
level
matur
activ
form
enzym
strongli
reduc
cathepsin
b
synthes
preprocathepsin
b
membranebound
ribosom
follow
transport
golgi
apparatu
preprocathepsin
b
glycosyl
mannosecontain
oligosaccharid
target
procathepsin
b
lysosom
receptordepend
dissoci
receptor
well
proteolyt
process
matur
cathepsin
b
requir
acidif
compart
cancer
cell
vatpas
inhibit
archazolid
impair
receptormedi
traffick
transgolgi
network
prelysosom
compart
result
decreas
activ
lysosom
proteas
like
cathepsin
b
assum
archazolidinduc
decreas
cathepsin
b
activ
express
base
mechan
interestingli
overexpress
cathepsin
b
attenu
archazolidinduc
adhes
breast
cancer
cell
onto
endotheli
cell
indic
adhes
neg
correl
express
cathepsin
b
cathepsin
b
also
degrad
extracellular
matrix
compon
fibronectin
laminin
vatpas
inhibit
could
lead
accumul
protein
increas
adhes
cell
express
fibronectin
laminin
receptor
howev
focu
ecm
compon
sinc
relev
adhes
cell
cell
predominantli
adher
collagen
adhes
jurkat
cell
mostli
independ
ecm
protein
collagen
fibronectin
laminin
fig
interestingli
archazolidinduc
cell
adhes
onto
endothelium
result
decreas
transendotheli
migrat
cell
contrast
haidari
et
al
show
adhes
cell
onto
huvec
induc
tyr
phosphoryl
vascular
endotheli
cadherin
dissoci
catenin
vecadherin
complex
retract
endotheli
cell
facilit
transendotheli
migrat
tumor
cell
moreov
tyr
phosphoryl
vecadherin
mediat
activ
hrasrafmekerk
signal
cascad
inhibit
hra
huvec
block
transendotheli
migrat
cell
hepat
cancer
cell
archazolid
reduc
rasrafmekerk
signal
alter
membran
composit
fluiditi
assum
archazolid
affect
endotheli
cell
similar
way
lead
inhibit
ra
signal
therefor
reduc
transendotheli
migrat
cell
taken
togeth
studi
show
archazolid
reduc
activ
express
cathepsin
b
endotheli
cell
result
amount
collagen
surfac
endotheli
cell
significantli
upregul
final
result
increas
adhes
metastat
cancer
cell
line
onto
archazolidtr
endotheli
cell
wherea
adhes
nonmetastat
jurkat
cell
unaffect
studi
show
vatpas
play
import
role
regul
adhes
cell
express
receptor
extracellular
matrix
compon
archazolid
repres
promis
tool
elucid
role
vatpas
endotheli
cell
moreov
first
time
link
function
vatpas
adhes
transmigr
tumor
cell
onto
endotheli
cell
well
remodel
extracellular
matrix
surfac
endotheli
cell
fact
adhes
metastat
tumor
cell
onto
endotheli
cell
increas
transendotheli
migrat
reduc
upon
inhibit
endotheli
vatpas
archazolid
support
view
archazolid
potenti
antimetastat
compound
